Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.72 |
| ▸ | NPY2R | P49146 | 1/20 | 0.72 |
| ▸ | NPY4R | P50391 | 1/20 | 0.72 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.72 |
| ▸ | GLP1R | P43220 | 12/20 | 0.69 |
| ▸ | CCKBR | P32239 | 2/20 | 0.69 |
| ▸ | CALCR | P30988 | 4/20 | 0.69 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.67 |
| ▸ | GCGR | P47871 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416095 | 1.00 | NPY1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30692442 | 1.00 | NPY1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL29991271 | 0.95 | GLP1R (0.73) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30721558 | 0.94 | NPY1R (0.72) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30658209 | 0.94 | NPY1R (0.73) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30721620 | 0.94 | NPY1R (0.72) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL31182708 | 0.94 | NPY1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30721629 | 0.94 | GLP1R (0.70) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL29706260 | 0.94 | GLP1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30721577 | 0.94 | NPY1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |